
Friday, March 22, 2024 10:43:07 AM
By TPN/Lusa, in News, Portugal, Business, Porto & North · 1 hour ago
LINK
German footwear brand Birkenstock is investing 15 million euros in Arouca to operate a production unit there with more than 600 direct jobs being created.
According to data from the Municipal Council of the district of Aveiro, the German multinational acquired as a subsidiary the single-person company S&CC Portugal, which had already been operating in the sector since 2003, and is next to the current facilities of the firm that it is building a new unit, 10 times larger in size.
The new factory should be completed by December 2024 and will occupy 13,000 square meters in the São Domingos Industrial Zone, involving a workforce that, by 2025, should reach 600 to 650 direct jobs.
For the mayor of Arouca, Margarida Belém, “the attraction of this foreign direct investment by the Birkenstock economic group results from several competitive factors in the country, the region and the municipality”.
The socialist mayor explains: “Arouca is today an active part of an ecosystem of innovation and business development based on the areas of intelligent specialization in its region, among which creativity and the symbolic capital of fashion stand out – which includes footwear” .
Considering the reputation of the brand which, according to Fortune and Forbes magazines, in 2022 it sold more than 30 million pairs of shoes to around 100 countries, Margarida Belém expects from Birkenstock “a commitment to differentiation, quality and knowledge”, of which should result in “significant direct and indirect impacts (for the municipality) such as the creation of new jobs, population retention, attraction of new residents and boosting added value”.
The mayor also highlights that the investment of 15 million euros is also associated with the commitment that the German multinational demonstrates “an attitude of social and environmental responsibility, which, in conjunction with current public policies, will certainly contribute positively to the local and regional development dynamics”.
According to an internal Birkenstock publication that Lusa had access to, the new factory will have a leisure area on the roof and a kindergarten prepared to accommodate 50 children. The company also intends to “provide free transport to employees, so that they can go to work without having to use their cars”.
I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of them.
Recent BIRK News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2025 08:15:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/06/2025 08:32:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/06/2025 08:31:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2025 08:15:06 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/30/2025 03:02:32 PM
- Form 424B7 - Prospectus [Rule 424(b)(7)] • Edgar (US Regulatory) • 05/29/2025 05:13:30 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/29/2025 08:15:02 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/15/2025 10:03:49 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/06/2025 11:01:06 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/20/2025 11:03:06 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/20/2025 11:02:02 AM
- Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 02/13/2025 09:15:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/21/2025 12:02:30 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/16/2025 11:01:09 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/10/2025 11:08:33 AM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/18/2024 12:02:48 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/18/2024 11:03:29 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 11:21:55 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/07/2024 11:35:03 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 08:15:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/12/2024 08:16:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/30/2024 08:16:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/30/2024 01:38:03 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/29/2024 10:19:44 AM
- U.S. Futures Rise; Oil Prices Dip Amid Libyan Supply Concerns and Inventory Drop • IH Market News • 08/29/2024 10:11:58 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM